-
-
-
-
-
-
-
Repligen (RGEN) Purchases Bioprocessing Analytics Portfolio from 908 Devices (MASS)
-
-
-
-
-
-
-
908 Devices Appoints Michele M. Leonhart, Former Administrator of the United States Drug Enforcement Administration (DEA), to Its Board of Directors
-
-
-
-
-
-
-
908 Devices Reports Second Quarter 2023 Financial Results and Updates 2023 Revenue Outlook
-
-
-
-
-
-
-
908 Devices Inc. (MASS) Prices 3.15M Share IPO at $32/sh
-
-
-
-
-
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

